Clinical trial

Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol…

NCT00092586 · Organon and Co, Industry · Completed

Key facts

NCT number NCT00092586
Title Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)
Official title A Multi-center, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, 6-Week Study to Evaluate the Efficacy and Safety of Ezetimibe 10 mg/Day When Added to Ongoing Therapy With a Statin Versus Statin Therapy Alone, in Patients With Hypercholesterolemia Who Have Not Reached National…
Lead sponsor Organon and Co, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hypercholesterolemia
Intervention type Drug
Interventions MK0653, ezetimibe, Comparator: statins
Enrollment 2,904
Start date Sep 1, 2002
Primary completion Oct 1, 2003
Completion Oct 1, 2003
First posted Sep 28, 2004
Last update posted Aug 15, 2024

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies